Vanillin

Vanillin

SCHEMBL2907529

COC.COc1cc(C=O)ccc1O

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.96
HPGD P15428 2/20 0.96
TDP1 Q9NUW8 2/20 0.96
TRIM24 O15164 1/20 0.96
ALDH5A1 P51649 1/20 0.96
ABAT P80404 1/20 0.96
TRIM33 Q9UPN9 1/20 0.96
AOX1 Q06278 1/20 0.70
XDH P47989 1/20 0.67
TSHR P16473 3/20 0.66
TRPA1 O75762 1/20 0.65
TYR P14679 2/20 0.62
NFE2L2 Q16236 3/20 0.62
CYP2D6 P10635 3/20 0.62
ALOX5 P09917 3/20 0.62
CYP1A2 P05177 3/20 0.62
NFKB1 P19838 2/20 0.62
HSD11B1 P28845 2/20 0.62
STAT3 P40763 2/20 0.62
NFKB2 Q00653 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vanillin SCHEMBL720723 0.98 ALDH1A1 (1.00) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL29354839 0.98 ALDH1A1 (1.00) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL1213 0.98 ALDH1A1 (1.00) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL19149274 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL20549709 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL8853913 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL19411839 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL8854077 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL11269339 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL4442606 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12324451-B2 Production of ethanol-free vanilla extracts SYMRISE AG (DE) 2025-06-10 US claimed
CN-117327744-A Method for synthesizing aromatic alcohol by catalyzing aromatic aldehyde by using wild bacillus and application of method 常州大学 2024-01-02 CN claimed
US-20230263202-A1 Production of Ethanol-free Vanilla Extracts SYMRISE AG (DE) 2023-08-24 US claimed
CN-114886801-B Polypeptide composition for anti-inflammatory and allergy-relieving repair, and preparation method and application thereof 浙江湃肽生物股份有限公司 2023-06-13 CN claimed
US-20210022381-A1 Production of Ethanol-free Vanilla Extracts SYMRISE AG (DE) 2021-01-28 US claimed
EP-3481440-B1 AIR FRESHENER PRODUCT COMPRISING A FRESHENING COMPOSITION COMPRISING ISOPROPYL MYRISTATE PROCTER & GAMBLE (US) 2025-03-05 EP disclosed
CN-119499119-A Oligopeptide composition with repairing function and preparation method thereof 山东济肽生物科技有限公司 2025-02-25 CN disclosed
US-20240398754-A1 VERATRALDEHYDE, PIPERONYL ALCOHOL, ETHYL 2-AMINO BENZOATE, ISOAMYL CINNAMATE, OR DIETHYL MALONATE AS FOOD ADDITIVES WITH ANTI-INFLAMMATORY PROPERTIES NATIONAL UNIVERSITY OF IRELAND, MAYNOOTH (IE) 2024-12-05 US disclosed
EP-4419090-A2 VERATRALDEHYDE, PIPERONYL ALCOHOL, ETHYL 2-AMINO BENZOATE, ISOAMYL CINNAMATE, OR DIETHYL MALONATE AS FOOD ADDITIVES WITH ANTI-INFLAMMATORY PROPERTIES National University of Ireland, Maynooth (IE) 2024-08-28 EP disclosed
CN-117486694-B Continuous preparation method of veratraldehyde 山东新和成药业有限公司 2024-03-26 CN disclosed
CN-117486694-A Continuous preparation method of veratraldehyde 山东新和成药业有限公司 2024-02-02 CN disclosed
CN-117327744-A Method for synthesizing aromatic alcohol by catalyzing aromatic aldehyde by using wild bacillus and application of method 常州大学 2024-01-02 CN disclosed
US-20080095731-A1 Personal Care Compositions Comprising Alpha-Glucans and/or Beta-Glucans PROCTER & GAMBLE COMPANY, THE 2008-04-24 US disclosed
US-20080075798-A1 Personal care compositions comprising pear seed extract PROCTER & GAMBLE COMPANY, THE 2008-03-27 US disclosed
WO-2008027533-A2 PERSONAL CARE COMPOSITIONS COMPRISING PEAR SEED EXTRACT THE PROCTER & GAMBLE COMPANY (US) 2008-03-06 WO disclosed
US-20070196296-A1 Personal care compositions PROCTER & GAMBLE COMPANY, THE 2007-08-23 US disclosed
US-20070185038-A1 Regulation of mammalian keratinous tissue using skin care actives THE PROCTER & GAMBLE COMPANY 2007-08-09 US disclosed
US-20070183993-A1 Personal care compositions PROCTER & GAMBLE COMPANY, THE 2007-08-09 US disclosed
WO-2007041548-A2 COMPOSITION FOR REGULATION OF MAMMALIAN KERATINOUS TISSUE THE PROCTER & GAMBLE COMPANY (US) 2007-04-12 WO disclosed
WO-2007001904-A2 PERSONAL CARE COMPOSITIONS COMPRISING ALPHA-GLUCANS AND/OR BETA-GLUCANS THE PROCTER & GAMBLE COMPANY (US) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070196296-A1 Personal care compositions CUTA, C5, F7 ALDH1A1 3550/4885HPGD 1444/4885TDP1 1957/4885
US-20070183993-A1 Personal care compositions PPARG, PPARA, PPARD ALDH1A1 2805/4885HPGD 662/4885TDP1 2918/4885
US-20080095731-A1 Personal Care Compositions Comprising Alpha-Glucans and/or Beta-Glucans HEXA, TYR, HEXB ALDH1A1 3012/4885HPGD 1021/4885TDP1 2466/4885
US-20080075798-A1 Personal care compositions comprising pear seed extract CUTA, POLR1C, DPM1 ALDH1A1 3508/4885HPGD 3653/4885TDP1 2113/4885
US-20240398754-A1 VERATRALDEHYDE, PIPERONYL ALCOHOL, ETHYL 2-AMINO BENZOATE, ISOAMYL CINNAMATE, OR DIETHYL MALONATE AS FOOD ADDITIVES WITH ANTI-INFLAMMATORY PROPERTIES MAL2, NFKBIA, DLAT ALDH1A1 59/4885HPGD 1211/4885TDP1 3138/4885
US-20070185038-A1 Regulation of mammalian keratinous tissue using skin care actives CUTA, KDM7A, KDM2A ALDH1A1 3455/4885HPGD 2220/4885TDP1 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.